The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
// STATE LEGISLATION TRACKER

Missouri HB 2758: Modifies provisions relating to the regulation of abortion

โš–๏ธ NEUTRAL for peptide users ๐Ÿ‘ค NONE user impact ๐Ÿ“œ Status: Failed
State
Missouri
Bill
HB 2758
Filed
2024-02-21
Read the bill
OpenStates โ†’
Last reviewed
2026-10-02

Plain-English Summary

Missouri HB2758 is an abortion-regulation bill, not a peptide, compounding, telehealth, or prescribing bill. Based on the available title and summaries, it does not appear to change access to compounded peptides, off-label prescribing, NP/naturopath scope, FDA 503A/503B rules, controlled substances, or PDMP requirements.

Key Points

  • No apparent change to compounded peptide access
  • No apparent change to off-label prescribing rules
  • No apparent change to telehealth peptide care
  • No apparent change to NP or naturopath scope
  • No apparent change to 503A or 503B compounding

What to Watch For

i
Note This appears limited to abortion law, so peptide users likely do not need to adjust care plans.
i
Note Monitor only if later amendments add broader reproductive-health or prescribing language.

Where the Bill Stands

The 2024 Missouri session ended without HB2758 passing, so the bill is considered dead or failed.
ยท Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.
Bill page generated 2026-11-04 ยท enriched via codex gpt-5.5
Source: OpenStates v3 API ยท View official bill ยท โ† back to all laws